March 23, 2026: Iran War De-Escalation Doubts, Trump Touts Truce Talks, More
Bloomberg News Now
00:00
Gilead Acquires Oromedicines
Charlie Pellett reports Gilead's deal to buy Oromedicines for up to $2.18 billion targeting antibody drugs.
Play episode from 04:28
Transcript
